Remove keyword women-life-sciences-2023
article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

CVD is the leading cause of mortality in women. Hospital admissions with acute coronary syndrome in women younger than 55 years increased 21% in 1995-1999 and 31% in 2010-2014. Many high school and college students are moving away from the sciences. The biggest barrier for CV medicine is the lack of women leaders in CV.